BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36108220)

  • 1. Loss of Epigenetic Regulation Disrupts Lineage Integrity, Induces Aberrant Alveogenesis, and Promotes Breast Cancer.
    Langille E; Al-Zahrani KN; Ma Z; Liang M; Uuskula-Reimand L; Espin R; Teng K; Malik A; Bergholtz H; Ghamrasni SE; Afiuni-Zadeh S; Tsai R; Alvi S; Elia A; Lü Y; Oh RH; Kozma KJ; Trcka D; Narimatsu M; Liu JC; Nguyen T; Barutcu S; Loganathan SK; Bremner R; Bader GD; Egan SE; Cescon DW; Sørlie T; Wrana JL; Jackson HW; Wilson MD; Witkiewicz AK; Knudsen ES; Pujana MA; Wahl GM; Schramek D
    Cancer Discov; 2022 Dec; 12(12):2930-2953. PubMed ID: 36108220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field cancerization in mammary carcinogenesis - Implications for prevention and treatment of breast cancer.
    Rivenbark AG; Coleman WB
    Exp Mol Pathol; 2012 Dec; 93(3):391-8. PubMed ID: 23142414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.
    Yuan W; Goldstein LD; Durinck S; Chen YJ; Nguyen TT; Kljavin NM; Sokol ES; Stawiski EW; Haley B; Ziai J; Modrusan Z; Seshagiri S
    Breast Cancer Res; 2019 Dec; 21(1):152. PubMed ID: 31881983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell lineage tracing links ERα loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype.
    Ding Y; Liu Y; Lee DK; Tong Z; Yu X; Li Y; Xu Y; Lanz RB; O'Malley BW; Xu J
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
    Scribner KC; Behbod F; Porter WW
    Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
    Citron F; Segatto I; Vinciguerra GLR; Musco L; Russo F; Mungo G; D'Andrea S; Mattevi MC; Perin T; Schiappacassi M; Massarut S; Marchini C; Amici A; Vecchione A; Baldassarre G; Belletti B
    Cancer Res; 2020 Mar; 80(5):1064-1077. PubMed ID: 31862778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.
    Caruso JA; Karakas C; Zhang J; Yi M; Albarracin C; Sahin A; Bondy M; Liu J; Hunt KK; Keyomarsi K
    Breast Cancer Res; 2014; 16(6):3417. PubMed ID: 25551582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
    Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
    Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.
    Elsarraj HS; Hong Y; Valdez KE; Michaels W; Hook M; Smith WP; Chien J; Herschkowitz JI; Troester MA; Beck M; Inciardi M; Gatewood J; May L; Cusick T; McGinness M; Ricci L; Fan F; Tawfik O; Marks JR; Knapp JR; Yeh HW; Thomas P; Carrasco DR; Fields TA; Godwin AK; Behbod F
    Breast Cancer Res; 2015 Sep; 17():128. PubMed ID: 26384318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis.
    Bi X; Hameed M; Mirani N; Pimenta EM; Anari J; Barnes BJ
    Breast Cancer Res; 2011; 13(6):R111. PubMed ID: 22053985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer.
    Li Q; Yao Y; Eades G; Liu Z; Zhang Y; Zhou Q
    Oncogene; 2014 May; 33(20):2589-600. PubMed ID: 23752191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
    Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
    Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer.
    Simigdala N; Chalari A; Sklirou AD; Chavdoula E; Papafotiou G; Melissa P; Kafalidou A; Paschalidis N; Pateras IS; Athanasiadis E; Konstantopoulos D; Trougakos IP; Klinakis A
    Cell Mol Life Sci; 2023 Mar; 80(4):100. PubMed ID: 36933062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating breast cancer by PIK3CA mutation.
    Miller TW
    Breast Cancer Res; 2012 Feb; 14(1):301. PubMed ID: 22315990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
    Asselin-Labat ML; Sutherland KD; Vaillant F; Gyorki DE; Wu D; Holroyd S; Breslin K; Ward T; Shi W; Bath ML; Deb S; Fox SB; Smyth GK; Lindeman GJ; Visvader JE
    Mol Cell Biol; 2011 Nov; 31(22):4609-22. PubMed ID: 21930782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
    Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
    Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.